India pharma turns to specialty drugs as generics pricing bite deepens

Price erosion in several mature molecules has continued through 2025 and into early 2026

India pharma turns to specialty drugs as generics pricing bite deepens
Price erosion in several mature molecules has continued through 2025 and into early 2026

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

DDP Editor Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.